ORGO
Organogenesis Holdings Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -8.4% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | +3 | 49.96M | $121.38M | +7 | −3 |
| Q1 2026 | 63 | -8 | 40.42M | $96.13M | +5 | −14 |
| Q4 2025 | 72 | +2 | 50.45M | $261.28M | +3 | — |
| Q3 2025 | 15 | -1 | 28.00M | $118.17M | — | −2 |
| Q2 2025 | 14 | -1 | 16.35M | $59.84M | — | −1 |
| Q1 2025 | 12 | +1 | 8.11M | $35.03M | +1 | — |
| Q4 2024 | 11 | 0 | 8.24M | $26.36M | — | — |
| Q3 2024 | 10 | 0 | 7.43M | $21.26M | — | — |
| Q2 2024 | 10 | — | 6.90M | $19.31M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.74M | -0.4% | $5.56M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.74M | -0.4% | $5.56M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 1.55M | — | $4.97M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 1.52M | -43.8% | $4.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 1.52M | -43.8% | $4.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.52M | -43.8% | $4.87M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 1.07M | +31.2% | $3.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 737.44K | -0.1% | $2.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 737.44K | -0.1% | $2.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 482.20K | 0.0% | $1.54M | 0.0% | Held | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 382.41K | +25.9% | $1.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 255.80K | +85.6% | $818,563 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 255.80K | +85.6% | $818,563 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 254.28K | +5.2% | $813,702 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 254.28K | +5.2% | $813,702 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 208.42K | +2.8% | $666,944 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 28.90K | -45.9% | $93,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 121 holders, 62.04M shares, $141.33M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.